SecBot SecBot
Insider Cluster (2 insiders) ·Filed Aug 14, 2026

LGND

LIGAND PHARMACEUTICALS INC
NEUTRAL
Impact 4/10
Horizondays Processed3mo ago
Insider cluster: 2 insiders, $11.3M total
Actionable Insight • Neutral

The cluster is consistent with routine post-earnings option exercise and diversification by two insiders. The $9.24M CFO sale is notable in absolute size but immaterial relative to the $5.8B market cap. No bearish signal, monitor for any additional insider sales in the next 30 days that would break the pattern of single-day post-vesting liquidity.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$291.77
T+0 close · Aug 14, 2026 · via day close
Latest settled
+7.67%
T+60 · $314.16
Vs SPY
+10.62%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 17 $291.77entry
  2. T+1 · 3mo ago −1.43%α −0.76% · $287.59
  3. T+5 · 3mo ago −3.97%α −2.78% · $280.18
  4. T+20 · 2mo ago −5.07%α −3.09% · $276.98
  5. T+60 · 7d ago +7.67%α +10.62% · $314.16

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CFO Octavio Espinoza and Director Jason Haas executed a cluster of derivative exercises and open-market sales on August 12, 2026, totaling $11.33M in gross proceeds. The sales follow Ligand's strong Q2 2026 earnings beat (EPS $2.37 vs $1.97 consensus) and the close of the XOMA Royalty acquisition, suggesting post-earnings liquidity and tax planning rather than a bearish signal. The $9.24M CFO sale is large in absolute terms but represents only ~0.16% of the $5.8B market cap, falling within the modest proportionality band, and the cluster is dominated by sales with no buys, consistent with routine post-vesting diversification.

Key Financial Metrics

Direction
selling
Total Value
$11.3M
Insiders
2

Key Facts

  • CFO Espinoza sold 31,641 shares at ~$292.07 for $9.24M on 2026-08-12
  • Director Haas sold 7,138 shares at ~$292.81 for $2.09M on 2026-08-12
  • All sales were preceded by derivative exercises at $0 or low strike prices, indicating option cashless exercises
  • Total cluster value of $11.33M is ~0.2% of LGND's $5.8B market cap
  • Cluster occurred 6 days after Q2 2026 earnings beat and guidance raise on 2026-08-06

Financial Impact

Total insider sales of $11.33M represent ~0.2% of market cap, within the modest proportionality band

insider ownershipfloat

Risk Factors

  • Further insider selling in coming weeks could indicate a shift in sentiment
  • The stock has rallied significantly post-earnings (implied by sale price ~$292 vs prior levels), increasing the risk of a pullback

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
93% bullish (15 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-LGND-1786741562872

US Market Status

Market Closed · Opens Wed (10h 19m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 14, 2026